Mingsong Li

2.2k total citations · 1 hit paper
63 papers, 1.4k citations indexed

About

Mingsong Li is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Mingsong Li has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Immunology and 16 papers in Genetics. Recurrent topics in Mingsong Li's work include Inflammatory Bowel Disease (15 papers), Gut microbiota and health (7 papers) and Microscopic Colitis (6 papers). Mingsong Li is often cited by papers focused on Inflammatory Bowel Disease (15 papers), Gut microbiota and health (7 papers) and Microscopic Colitis (6 papers). Mingsong Li collaborates with scholars based in China, United States and Malaysia. Mingsong Li's co-authors include Zhanju Liu, Jian Lin, Huiying Lu, Han Gao, Xiang Gao, Cui Zhang, Gengfeng Li, Zhitao Li, Ruixin Zhu and Fachao Zhi and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Mingsong Li

58 papers receiving 1.4k citations

Hit Papers

Microbiota metabolite butyrate constrains neutrophil func... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingsong Li China 21 784 316 293 184 181 63 1.4k
Guoxing Wang China 18 605 0.8× 503 1.6× 289 1.0× 214 1.2× 217 1.2× 43 1.5k
Isabelle Frey‐Wagner Switzerland 18 714 0.9× 314 1.0× 250 0.9× 230 1.3× 199 1.1× 33 1.3k
Jeremy A. Goettel United States 20 788 1.0× 581 1.8× 266 0.9× 149 0.8× 254 1.4× 50 1.8k
Hyunji Ryu United States 12 650 0.8× 369 1.2× 265 0.9× 98 0.5× 191 1.1× 15 1.3k
Jamma Trinath India 12 752 1.0× 381 1.2× 137 0.5× 226 1.2× 191 1.1× 26 1.5k
Karen L. Edelblum United States 21 774 1.0× 668 2.1× 331 1.1× 164 0.9× 305 1.7× 47 1.9k
Sam C. Nalle United States 11 719 0.9× 279 0.9× 288 1.0× 123 0.7× 277 1.5× 19 1.4k
Christian Barmeyer Germany 20 845 1.1× 198 0.6× 308 1.1× 213 1.2× 417 2.3× 28 1.7k
Anaïs Larabi France 8 618 0.8× 153 0.5× 185 0.6× 247 1.3× 136 0.8× 11 1.0k
Qingdong Guan Canada 17 609 0.8× 531 1.7× 591 2.0× 286 1.6× 278 1.5× 34 1.6k

Countries citing papers authored by Mingsong Li

Since Specialization
Citations

This map shows the geographic impact of Mingsong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingsong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingsong Li more than expected).

Fields of papers citing papers by Mingsong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingsong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingsong Li. The network helps show where Mingsong Li may publish in the future.

Co-authorship network of co-authors of Mingsong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mingsong Li. A scholar is included among the top collaborators of Mingsong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingsong Li. Mingsong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Qian, et al.. (2025). The multifaceted role of Sestrin 3 (SESN3) in oxidative stress, inflammation and tumorigenesis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1872(5). 119938–119938.
2.
Zhong, Guoqiang, et al.. (2024). Research progress of Ustekinumab in the treatment of inflammatory bowel disease. Frontiers in Immunology. 15. 1322054–1322054. 9 indexed citations
3.
Li, Mingsong, et al.. (2024). 古气候数据同化: 原理和展望. SCIENTIA SINICA Terrae.
4.
Ren, Xingxing, Qiuyuan Liu, Peirong Zhou, et al.. (2024). DHX9 maintains epithelial homeostasis by restraining R-loop-mediated genomic instability in intestinal stem cells. Nature Communications. 15(1). 3080–3080. 17 indexed citations
5.
Zhong, Guoqiang, et al.. (2024). Metabolomics reveals the potential metabolic mechanism of infliximab against DSS-induced acute and chronic ulcerative colitis. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(11). 8815–8824. 3 indexed citations
6.
Wang, Shanping, et al.. (2024). Application of Nanoparticles in the Diagnosis and Treatment of Colorectal Cancer. Anti-Cancer Agents in Medicinal Chemistry. 24(18). 1305–1326. 1 indexed citations
7.
Zhang, Cong, et al.. (2024). Causal association between inflammatory bowel disease and acute pancreatitis: a two-sample bidirectional mendelian randomization study. Frontiers in Genetics. 15. 1324893–1324893. 2 indexed citations
8.
Chen, Liang, Leilei Fang, Mingming Sun, et al.. (2024). Development and validation of a novel therapeutic drug monitoring-based nomogram for prediction of primary endoscopic response to anti-TNF therapy in active Crohn’s disease. Therapeutic Advances in Gastroenterology. 17. 1118439213–1118439213. 1 indexed citations
9.
Shi, Runjie, et al.. (2024). ERCC4: a potential regulatory factor in inflammatory bowel disease and inflammation-associated colorectal cancer. Frontiers in Endocrinology. 15. 1348216–1348216. 2 indexed citations
10.
Jing, Yongshuai, Wenjing Cheng, Mingsong Li, et al.. (2024). Preparation, characterization and drug release properties of pH sensitive Zingiber officinale polysaccharide hydrogel beads. International Journal of Biological Macromolecules. 263(Pt 1). 130376–130376. 9 indexed citations
11.
Li, Haojia, Qing Xin, Yuqi Hu, et al.. (2023). Mendelian randomization analysis reveals causality of inflammatory bowel disease on risks of Henoch-Schönlein purpura and immune thrombocytopenia. Digestive and Liver Disease. 56(1). 92–97. 2 indexed citations
12.
Li, Xiaxi, Wei Hu, Jiangang Shen, Mingsong Li, & Wei Gong. (2022). Targeting proteasome enhances anticancer activity of oncolytic HSV-1 in colorectal cancer. Virology. 578. 13–21. 2 indexed citations
13.
Zhou, Zheng, et al.. (2021). Evidence for the butyrate metabolism as key pathway improving ulcerative colitis in both pediatric and adult patients. Bioengineered. 12(1). 8309–8324. 12 indexed citations
14.
Li, Gengfeng, Jian Lin, Cui Zhang, et al.. (2021). Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease. Gut Microbes. 13(1). 1968257–1968257. 305 indexed citations breakdown →
15.
Lu, Huiying, Jian Lin, Mingming Sun, et al.. (2021). Cyclosporine modulates neutrophil functions via the SIRT6–HIF‐1α–glycolysis axis to alleviate severe ulcerative colitis. SHILAP Revista de lepidopterología. 11(2). e334–e334. 73 indexed citations
16.
Fang, Leilei, Han Gao, Xiang Gao, et al.. (2021). Risks of Cardiovascular Events in Patients With Inflammatory Bowel Disease in China: A Retrospective Multicenter Cohort Study. Inflammatory Bowel Diseases. 28(Supplement_2). S52–S58. 11 indexed citations
17.
Xiong, Wenjun, et al.. (2018). Downregulation of KMT2D suppresses proliferation and induces apoptosis of gastric cancer. Biochemical and Biophysical Research Communications. 504(1). 129–136. 33 indexed citations
18.
Zhou, Youlian, Zhenjiang Zech Xu, Yan He, et al.. (2018). Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction. mSystems. 3(1). 247 indexed citations
19.
Zhao, Wenzhen, et al.. (2016). [Efficacy of Yunnan Baiyao as an adjuvant treatment for active ulcerative colitis: an open-label randomized controlled study].. PubMed. 36(9). 1186–1191. 2 indexed citations
20.
Ma, Qiang, Bin Zhang, Xiguang Xu, et al.. (2013). Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis. Science China Life Sciences. 56(3). 234–239. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026